The Boston Globe to Host Rare Disease Summit
Second Annual Rare Disease Summit to Bring Together Advocates, Experts, and Industry Leaders,
Following last year's success, the second annual Rare Disease Summit unites key advocates, researchers, and policymakers, as well as nonprofits and companies, working to enact medical breakthroughs and meaningful change in patient care. Sessions will be moderated by Boston Globe journalists leading coverage on the region's biggest health and medical stories.
"At Boston Globe Media, we're dedicated to uniting the community with the region's movers and shakers," said
Sessions for the 2026 Rare Disease Summit include:
- Living It, Leading It: When Lived Rare Disease Experience Becomes Professional Purpose
- Stronger Together: Navigating Shared Decision-Making in Genetic Skeletal Conditions
- Coast to Coast: Innovation Without Borders
- Mental Health in Rare Disease: Breaking the Silence
- Generation Rare: Young Voices Changing the Conversation
- Recognizing the Realities of Hypoparathyroidism: Advocating for and Addressing
Patient Needs - The Power of the Parent Voice: Advocacy and Progress in Rare Cancer and Disease
The Boston Globe is hosting the Rare Disease Summit in partnership with Biotech Tuesday! and presenting sponsor Alexion, AstraZeneca Rare Disease. Supporting sponsors include Ascendis Pharma, BioMarin, Chiesi Global Rare Diseases, and Rocket Pharma.
In-person tickets — including a complimentary lunch — are available for the day of programming, happening live at Big
Contact: Boston Globe Media Communications, 617-851-3396, [email protected]
About Boston Globe Media:
Boston Globe Media Partners, LLC is a locally owned, award-winning media company serving
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-boston-globe-to-host-rare-disease-summit-302686921.html
SOURCE Boston Globe Media
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share